top of page

Title: European Stocks Higher After Chinese Rate Cut; Unilever Tumbles on GSK Unit Bid

  • Writer: analysiswatch
    analysiswatch
  • Jan 17, 2022
  • 1 min read

Jan 17, 2022 06:01AM ET


By: AnalysisWatch


European stock markets broadly advanced on Monday, supported by the Chinese central bank's measures to shore up the weakening economy.


China's central bank cut the interest rate on one-year loans for the first time in two years, signaling its intention to put a safety net under the economy, whose zero interest rate policy and property and financial sectors are under varying degrees of pressure.


Although China's fourth-quarter growth figures were better than expected, they showed a sharp slowdown in retail sales growth in December as the northern hemisphere winter ushered in a new round of local mobility restrictions. Many of Europe's largest consumer and industrial stocks are highly dependent on the Chinese market.


At 5:45 AM ET (1045 GMT), the Euro Stoxx 600 index was 0.5% higher at 483.58, while Germany's DAX index was up 0.3%, Britain's FTSE 100 was up 0.6%, and France's CAC 40 was up 0.5%.


Credit Suisse shares slumped another 1.6% after its chairman, Antonio Horta Osario, appointed less than a year ago to halt the bank's alarming decline in value, was sacked after repeated breaches of COVID-19 protocols. The bank is routinely traded as a takeover target after a spectacular fall from grace marked by embarrassingly public management feuds and some catastrophic miscalculations, most notably involving collapsed private office Archegos and disgraced Australian financier Lex Greensill.

With no trading in the US and a news blackout imposed by the Federal Reserve, the foreign exchange market failed to gain momentum. The euro slipped to $1.1420 as expectations grew that the European Central Bank would be forced to bring forward its monetary tightening timetable.

 
 
 

Comments


2b94f773-a237-4da7-a599-6b42314ed9e6.png

Risk Disclosure: AnalysisWatch will not accept any liability for loss or damage as a result of reliance on the information contained within this website including data, quotes, charts and buy/sell signals. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. Currency trading on margin involves high risk, and is not suitable for all investors. Before deciding to trade foreign exchange or any other financial instrument you should carefully consider your investment objectives, level of experience, and risk appetite.
AnalysisWatch would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore AnalysisWatch doesn’t bear any responsibility for any trading losses you might incur as a result of using this data.

bottom of page